TD Asset Management
SANA icon

TD Asset Management’s Sana Biotechnology SANA Stock Holding History

TD Asset Management’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-80,600
Closed -$328K – 1292
2025
Q4 		$328K Buy
+80,600
New +$361K ﹤0.01% 1197
2025
Q3 		– Sell
-309,034
Closed -$844K – 1281
2025
Q2 		$844K Hold
309,034
– – ﹤0.01% 1082
2025
Q1 		$519K Sell
309,034
-95,314
-24% -$266K ﹤0.01% 1144
2024
Q4 		$659K Hold
404,348
– – ﹤0.01% 1154
2024
Q3 		$1.73M Hold
404,348
– – ﹤0.01% 1083
2024
Q2 		$2.21M Sell
404,348
-116,764
-22% -$930K ﹤0.01% 963
2024
Q1 		$5.21M Buy
521,112
+158,460
+44% +$1.19M ﹤0.01% 769
2023
Q4 		$1.48M Hold
362,652
– – ﹤0.01% 1094
2023
Q3 		$1.4M Buy
362,652
+181,326
+100% +$975K ﹤0.01% 1056
2023
Q2 		$1.08M Buy
181,326
+47,100
+35% +$271K ﹤0.01% 1114
2023
Q1 		$439K Hold
134,226
– – ﹤0.01% 1285
2022
Q4 		$530K Buy
134,226
+12,200
+10% +$59.7K ﹤0.01% 1278
2022
Q3 		$681K Buy
122,026
+29,000
+31% +$209K ﹤0.01% 1244
2022
Q2 		$598K Buy
93,026
+44,800
+93% +$285K ﹤0.01% 1263
2022
Q1 		$398K Buy
48,226
+12,500
+35% +$101K ﹤0.01% 1364
2021
Q4 		$553K Hold
35,726
– – ﹤0.01% 1370
2021
Q3 		$805K Hold
35,726
– – ﹤0.01% 1303
2021
Q2 		$582K Hold
35,726
– – ﹤0.01% 1362
2021
Q1 		$1.2M Buy
+35,726
New +$1.16M ﹤0.01% 1229

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

TD Asset Management's SANA Position: Q1 2026 in Review

TD Asset Management sold out of Sana Biotechnology (SANA) in Q1 2026, closing a stake of 80,600 shares — an estimated $328K sold.

TD Asset Management first reported a position in SANA in Q1 2021 and held it in 19 quarters. The position peaked at $5.21M in Q1 2024. 202 funds tracked by Wall St. Rank hold SANA as of Q1 2026.

  • TD Asset Management reported no remaining Sana Biotechnology position as of Q1 2026 after selling out during the quarter.
  • TD Asset Management sold 80,600 Sana Biotechnology shares in Q1 2026, an estimated $328K.
  • TD Asset Management first reported a position in Sana Biotechnology in Q1 2021 and held it in 19 quarters.
  • TD Asset Management's Sana Biotechnology position peaked at $5.21M in Q1 2024.
  • 202 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2026.

Based on TD Asset Management's 13F filing for Q1 2026, filed 11 May 2026.